InsiderClue
Insiders · Profile

George Christopher Allen

SVP and CHIEF INFORMATION OFF at Ernexa Therapeutics. Filing since 29 Nov 2010. CIK 0001492419

Company
Date
Role
Action
Shares
Amount
Of holding
ERNA Ernexa Therapeutics Inc.
29 Nov 2010
SVP and CHIEF INFORMATION OFF
Bought
600
$210.00
opened
1 decision on file.